Académique Documents
Professionnel Documents
Culture Documents
Nursing Case Study Admission/ Final Diagnosis I. Health History A. DEMOGRAPHICAL DATA Clients Initials: Gender: Age: 80 Female D. G. B
Religion: Iglesia ni Cristo Occupation: Self - employed Usual Source of Medical Care: Hospital Date of Admission: June 18, 2011 Initial Diagnosis: T/C AMI, DM Type 2
B. SOURCE AND RELIABILITY OF INFORMATION Information that was obtained came from the patient's chart. The patient at the time was unconscious and unable to speak.
C. REASONS FOR SEEKING CARE OR CHIEF COMPLAINTS Chest Pain Loss of Conscious Difficulty in breathing
D.HISTORY OF PRESENT ILLNESS/ OR PRESENT HEALTH The patient was admitted on June 18, 2011. The initial diagnosis of the patient was Acute Myocardial Infarction, DM Type 2. The patient was
G. REVIEW OF SYSTEM AND PHYSICAL EXAMINATION 1. ROS and PE June 28, 2011 REVIEW OF SYSTEM PHYSICAL EXAMINATION OBJECTIVE DATA COMMON SIGNS AND SYMPTOMS SIGNIFICANCE
SYSTEM
No verbal cues
Unconscious Cyanotic
Weakness Fatigue
Unconsciousnes s: Inadequate cerebral perfusion and cardiogenic shock Cyanosis: Inadequate oxygenated blood circulation
No verbal cues
Sweating
J. Respiratory
No verbal cues
(+) Gasping
Shortness of Breath
K. Cardiovascula r
No verbal cues
Heartburn
Musculoskeletal
al
cues
body Infection:
Procedur e
Procedure Date
Indication
Normal Values
Chest Xray
6/23,25/1 1 7/3/11
A projection radiograph of the chest used to diagnose conditions affecting the chest, its contents, and nearby structures. Chest radiographs are among the most common films taken, being diagnostic of many
Further Progression in Pulmonary Edema with possible underlying pneumonia. Evidence of consolidation on the left upper lobe, subcutaneaus emphysema as seen with the tracheostomy tube in place.
conditions.
Gram Staining
6/23/11
An empirical m ethod of differentiating b acterial species into two large groups (Grampositive and Gr am-negative) based on the chemical, primarily the presence of Negative high levels infection of peptidoglyca n, and physical properties of their cell walls. [1] The Gram stain is almost always the first step in the identification of a bacterial organism. A blood test that is performed using blood fro m an artery. It involves puncturing an artery with a thin needle and syringe and drawing a small volume of blood. The most common
ABG
7/5/11
pH = 7.62 pCO2 = 23.2 pO2 = 111.2 HCO3 = 23.3 BE= 3.9 02 sat. = 98.9%
Color = Yellow Transperancy = Hazy An array of tests performed on urine and one of the most common methods of medical diagnosis. A part of a urinalysis can be performed by using urinedipsticks, in which the test results can be read as color changes. Reaction = 6.0 Gravity = 1.030 Chem. Exam. Albumin = Trace Sugar = Regular Pus = 12-15 HPF RBC = 4-6 HPF Epithelial cells = Moderate Others = Yeast cells Abundant
Urinalysis 7/2/11
3. OTHER ASSESSMENT TOOLS Date Taken Comprehensive Actual Content/ Legend Actual Result
10
11
Blood Flow of the Heart The heart is completely divided into a right and left halves. These 2 halves of the heart act as separate pumps, and there is no mixing of blood between
12
The right heart pumps blood to the pulmonary circuit, where the blood picks up oxygen from the lungs. The left heart then pumps it into the systemic circuit, where the blood delivers oxygen to the tissues that need it. Finally, the blood returns to the right heart and the cycle repeats itself.
Blood always leave the heart through arteries, which include the aorta and pulmonary arteries. Conversely, blood enters the heart through the veins, the largest being the pulmonary veins the vena cava.
13
14
MEDICAL SURGICAL MANAGEMENT 1. Procedure (Surgery) Procedure/ Date Indication/ Analysis Tracheostomy A tracheostomy is a surgical procedure to create an opening through the neck into the trachea (windpipe). A tube is usually placed through this opening to provide an airway and to remove secretions from the lungs. This tube is called a tracheostomy tube or trach tube. Tracheostomy / July 5 2011 A tracheostomy may be done if you have:
A large object blocking the airway An inability to breathe on your own An inherited abnormality of the larynx or trachea Breathed in harmful material such as smoke, steam, or other toxic gases that swell and block the airway Cancer of the neck, which can affect breathing by pressing on the airway
15
Paralysis of the muscles that affect swallowing Severe neck or mouth injuries Surgery around the voicebox (larynx) that prevents normal breathing and swallowing
Monitoring of the central venous pressure (CVP) in acutely ill patients to quantify fluid balance. Long-term Intravenous antibiotics Long-term Parenteral nutrition especially in chronically ill patients. Central Venous Pressure / July 5 2011 Long-term pain medications Chemotherapy Frequent blood draws Frequent or persistent requirement for intravenous access Need for intravenous therapy when peripheral venous access is impossible Wound debridement / July 5 2011 An open wound or ulcer can not be properly evaluated until the dead tissue or foreign matter is removed. Wounds that contain necrotic and ischemic (low oxygen content) tissue take longer to
16
17
18
Assessment: INDICATION: 1. History: Hypersensitivity to Omeprazole or any of its components; pregnancy, lactation 2. Physical: skin lesions; reflexes; urinary output; abdominal examination; respiratory auscultation
-Maintenance of healing erosive esophagitis. -Duodenal Ulcers. Omeprazole(LO SEC) -Short-term treatment of active benign gastric ulcer. -Pathologic hyposecretor y condition, including zollingerellison syndrome. -Reduction of risk of GI bleeding in critically ill patient.
-Dizziness -Drowsiness -Fatigue -Headache -Weakness -Chest pain -Abdominal Pain -Acid Regurgitation -Constipation -Diarrhea -Flatulence -Nausea and Vomiting.
Interventions: 1. Administer before meals. 2. Administer antacids with, if needed. 3. Have regular medical follow-up visits. 4. Report severe headache, worsening of symptoms, fever, chills.
19
Lasix(FUROSE MIDE)
Diuretics
GI Drug Laxative
20
Imdur Tablets are indicated for the prevention of angina pectoris due to coronary artery disease. The onset of action of oral isosorbide mononitrate is not sufficiently rapid for this product to be useful in aborting an acute anginal episode.
Discontinued: Autonomic Nervous System Disorders: Dry mouth, hot flushes. Body as a Whole: Asthenia, back pain, chest pain, edema, fatigue, fever, flu-like symptoms, malaise, rigors. Cardiovascular Disorders, General: Cardiac failure, hypertension, hypotension. Central and Peripheral Nervous System Disorders: Dizziness, headache, hypoesthesia, migraine, neuritis, paresis, paresthesia, ptosis, tremor, vertigo. Gastrointestinal System Disorders: Abdominal pain, constipation, diarrhea, dyspepsia, flatulence, gastric ulcer, gastritis, glossitis, hemorrhagic gastric ulcer, For most patients, this can be accomplished by taking the dose on arising.
21
22
23
Overdose The toxicity of the product in large overdoses will be that of the liposoluble vitamin D. Prolonged daily intake of larger amounts can cause symptoms of chronic toxicity such as vomiting, headache, drowsiness and diarrhoea. Acute symptoms are only seen at even higher doses.
24
25
ADVERSE REACTION: -Exfoliative skin disorders -Serious hepatic effects -Blood dyscrasias (eosinophilia, thrombocytopenia, anemia, leukopenia)
PATIENT
26